Glycorex Transplantation AB Logo

Glycorex Transplantation AB

Develops technology to remove antibodies, enabling organ transplants across blood groups.

GTAB | NGM

Overview

Corporate Details

ISIN(s):
SE0000524522 (+1 more)
LEI:
549300BFHBYZ3X96EP25
Country:
Sweden
Address:
Scheelevägen 27, 223 63 Lund

Description

Glycorex Transplantation AB is a medical technology company that has developed a proprietary technology platform for the specific removal of antibodies from blood. The technology is based on biologically active carbohydrates for extracorporeal blood treatment. Its flagship product, Glycosorb® ABO, is a single-use medical device that enables organ transplantation across the blood group barrier, primarily for kidney, liver, heart, and stem cell transplants. Used clinically since 2001, the product has facilitated over 6,000 ABO-incompatible transplants with documented long-term results comparable to blood group compatible procedures. The company is leveraging its core technology to expand into new applications, including a product for creating universal blood plasma for transfusions and developing novel treatments for autoimmune diseases, with an initial focus on rheumatoid arthritis.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-04-29 14:55 Swedish 8.7 MB
2024-02-28 08:00 Swedish 3.1 MB

Automate Your Workflow. Get a real-time feed of all Glycorex Transplantation AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Glycorex Transplantation AB

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Glycorex Transplantation AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

3-D Matrix,Ltd. Logo
Develops peptide-based hydrogels to control bleeding in surgical procedures.
Japan
7777
aap Implantate AG Logo
Develops, manufactures, and markets implants for the treatment of bone fractures.
Germany
AAQ1
AcouSort AB Logo
Develops acoustofluidic solutions for automated biological sample processing.
Sweden
ACOU
Adagio Medical Holdings, Inc. Logo
Develops cryoablation technologies for treating cardiac arrhythmias like VT.
United States of America
ADGM
ADVANCED MEDICAL SOLUTIONS GROUP PLC Logo
Develops and manufactures innovative tissue-healing technologies for surgery and woundcare.
United Kingdom
AMS
AETHLON MEDICAL INC Logo
Develops immunotherapeutic devices to deplete exosomes and viruses from the blood.
United States of America
AEMD
Affluent Medical Logo
Develops minimally invasive implants for structural heart disease and urology.
France
AFME
AIOBIO Co., Ltd. Logo
Develops AI-driven diagnostic platforms and imaging devices for dental care.
South Korea
447690
Airway Medix S.A. Logo
Develops single-use medical devices for mechanically ventilated patients.
Poland
AWM
ALIGN TECHNOLOGY INC Logo
Designs and manufactures clear aligners, intraoral scanners, and digital services.
United States of America
ALGN

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.